Total pancreatectomy: Indications, operative technique, and postoperative sequelae

Journal of Gastrointestinal Surgery

Volumn 11, Issue 2, 2007, Pages 209-216

  Heidt, David G ^a   Burant, Charles ^b   Simeone, Diane M ^a,b,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Chronic pancreatitis; Diabetes; Pancreatectomy; Pancreatic neoplasms

Indexed keywords

CHRONIC DISEASE; FATTY LIVER; HUMAN; INTRACTABLE PAIN; LIVER FAILURE; METHODOLOGY; PANCREAS EXOCRINE INSUFFICIENCY; PANCREAS RESECTION; PANCREAS TUMOR; PANCREATITIS; QUALITY OF LIFE; REVIEW;

CHRONIC DISEASE; EXOCRINE PANCREATIC INSUFFICIENCY; FATTY LIVER; HUMANS; LIVER FAILURE; PAIN, INTRACTABLE; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATITIS; QUALITY OF LIFE;

EID: 34548428729     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-006-0025-7     Document Type: Review

References (70)

1. Sauve L. Des pancreatectemies et specialement de la pancreatectomie cephalique. Rev Chir 1908;37:113-152.
2. Rockey EW. Total pancreatectomy for carcinoma: Case Report. Ann Surg 1943;118:603-611.
3. Warren KW, Poulantzas JK, June GA. Life after total pancreatectomy for pancreatitis. Ann Surg 1966;164:830-834.
4. Stone WM. Chronic pancreatitis: results of Whipple's resection and total pancreatectomy. Arch Surg 1988;123(7):815-819.
5. Gall FP, Muhe E, Gebhardt C. Results of partial and total pancreaticoduodenectomy in 117 patients with chronic pancreatitis. World J Surg 1981;5(2):269-275.
6. Braasch JW, Vito L, Nugent FW. Total pancreatectomy of end-stage chronic pancreatitis. Ann Surg 1978;188(3):317-322.
7. Sarr MG, Sakorafas GH. Incapacitating pain of chronic pancreatitis: a surgical perspective of what is known and what is not known. Gastrointest Endosc 1999;49:S85-S89.
8. Warshaw AL, Banks PA, Fenandez-del Castillo C. Treatment of pain in chronic pancreatitis. Gastroenterology 1998;115(3):765-776.
9. Gruessner RWG, Sutherland DER, Dunn DL, Najarian JS, Jie T, Hering BJ, Gruessner AC. Transplant options for patients undergoing total pancreatectomy for chronic pancreatitis. J Am Coll Surg 2004;198:559-567.
10. Ricordi C, Lacy PE, Scharp DW. Automated islet isolation from human pancreas. Diabetes 1989;38:140-142.
11. Rodriguez-Rilo HL, Ahmad SA, D'Alessio D, Iwanaga Y, Kim J, Choe KA, Moulton JS, Martin J, Pennington LJ, Soldano DA, Biliter J, Martin SP, Ulrich CD, Somogyi L, Welge J, Matthews JB, Lowy AM. Total pancreatectomy and autologous islet cell transplantation as a means to treat severe chronic pancreatitis. J Gastrointest Surg 2003;7(8):978-989.
12. Clayton HA, Davies JE, Pollard CA, White SA, Musto PP, Dennison AR. Pancreatectomy with islet autotransplantation for the treatment of severe chronic pancreatitis: the first 40 patients at the Leichester General Hospital. Transplantation 2003;76:92-98.
13. Ricordi C, Inverardi L, Kenyon NS, Goss J, Bertuzzi F, Alejandro R. Requirements for success in clinical islet transplantation. Transplantation 2005;79(10):1298-1300 (May 27).
14. Buchler MW, Wagner M, Schmied BM, Uhl W, Friess H, Z'graggen K. Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg 2003;138:1310-1314.
15. Lin JW, Cameron JL, Yeo CJ, Riall TS, Lillemoe KD. Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula. J Gastrointest Surg 2004;8(8):951-959 (Dec).
16. Munoz-Bongrand N, Sauvanet A, Denys A, Sibert A, Vilgrain V, Belghiti J. Conservative management of pancreatic fistula after pancreaticoduodenectomy with pancreaticogastrostomy. J Am Coll Surg 2004;199(2):198-203 Aug.
17. Collins JJ, Craighead JE, Brooks JR. Rationale for total pancreatectomy for carcinoma of the pancreatic head. N Engl J Med 1966;274:599-602.
18. Van Heerden JA, ReMine WH, Weiland LH, McIlrath DC, ILstrup DM. Total pancreatectomy for ductal adenocarcinoma of the pancreas: Mayo Clinic experience. Am J Surg 1981;142:308-311.
19. Ihse I, Lilja P, Anresjo B, Bengmark S. Total pancreatectomy for cancer: an appraisal of 65 cases. Ann Surg 1977;186:675-680.
20. Kloppel G, Lohse T, Bosslet K, Ruckert K. Ductal adenocarcinoma of the head of the pancreas: incidence of tumor involvement beyond the whipple resection line. Histological and immunocytochemical analysis of 37 total pancreatectomy specimens. Pancreas 1987;2:170-175.
21. Motojima K, Urano T, Nagata Y, Shiku H, Tsurfune T, Kanematsu T. Detection of point mutations in the Kristen-ras oncogene provides evidence for the multicentricity of pancreatic adenocarcinoma. Ann Surg 1993;217(2):138-143.
22. Ihse I, Anderson H, Andren-Sandberg A. Total pancreatectomy for cancer of the pancreas: is it appropriate? World J Surg 1996;20:288-294.
23. Sarr MG, Behrns KE, vanHeerden JA. Total pancreatectomy: an objective analysis of its use in pancreatic cancer. Hepatogastroenterol 1993;40:418-421.
24. Karpoff H, Klimstra DS, Brennan MF, Conlon KC. Results of total pancreatectomy for adenocarcinoma of the pancreas. Arch Surg 2001;136:44-47.
25. Bartsch DK. Familial pancreatic cancer. Br J Surg 2003;90:386-387.
26. Lynch HT, Lanspa SJ, Fitzgibbons RJ, Smyrk T, Fitzsimmons ML, McClellan J. Familial pancreatic cancer: genetic pathology review. Nebr Med J 1989;74:109-112.
27. Klein AP, Brune KA, Petersen GM, Goggins M, Tersmette AC, Offerhaus GJ, Griffin C, Cameron JL, Yeo CJ, Kern S, Hruban RH. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 2004;64(7):2634-2638.
28. Hahn SA, Greenhalf B, Ellis I, Sina-Frey M, Rieder H, Korte B, Gerdes B, Kress R, Ziegler A, Raeburn JA, Campra D, Grutzmann R, Rehder H, Rothmund M, Schmiegel W, Neoptolemos JP, Bartsch DK. BRCAZ germline mutations in familial pancreatic cancer. J Natl Cancer Inst 2003;5:180-181.
29. Eberle MA, Pfutzer R, Pogue-Geile KL, Bronner MP, Crispin D, Kimmey MB, et al. A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34. Am J Hum Genet 2002;70:1044-1048.
30. Greenhalf W, McFaul C, Earl J, Howes N, Neoptolemos J, Kress R, Sina-Frey M, Rieder H, Hahn SA, Bartsch D. Anticipation in familial pancreatic cancer. Gut 2006;2155(2):252-258.
31. Reider H, Sina-Frey M, Ziegler A, Hahn SA, Przypadlo E, Kress R, et al. German national case collection of familial pancreatic cancer-clinical-genetic analysis of the first 21 families. Onkologie 2002;25:262-266.
32. Tersmette AC, Petersen GM, Offerhaus GJ, Falatko FC, Brune KA, Goggins M, et al. Increased risk of incident pancreatic cancer among first-degree relatives with familial pancreatic cancer. Clin Cancer Res 2001;7:738-744.
33. Brentnall TA. Cancer surveillance of patients from familial pancreatic cancer kindreds. Med Clin North Am 2000;84(3):707-718.
34. Rulyak SJ, Brentnall TA. Inherited pancreatic cancer: surveillance and treatment strategies for affected families. Pancreatology 2001;1(5):477-485.
35. Charpentier KP, Brentnall TA, Bronner MP, Byrd D, Christopher M. A new indication for pancreas transplantation: high grade pancreatic dysplasia. Clin Transplant 2004;18:105-107.
36. Thompson GB, Service FJ, van Heerden JA, Carney JA, Charboneau JW, O'Brien PC, Grant CS. Reoperative insulinomas, 1927 to 1992: an institutional experience. Surgery 1993;114(6):1196-1206.
37. Doherty GM, Olson JA, Frisella MM, Lairmore TC, Wells SA, Norton JA. Lethality of multiple endocrine neoplasia type I. World J Surg 1998;22:581-587.
38. Thompson NW. Invited commentary. World J Surg 1998;22(6):586-587.
39. Norton JA, Kivlen M, Li M, Schneider D, Chuter T, Jensen RT. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Arch Surg 2003;138:859-866.
40. Ohhashi K, Murakami Y, Takekoshi T, Ohta H, Ohhashi I. Four cases of "mucin-producing" cancer of the pancreas on specific findings of the papilla of Vater. Progress of Digestive Endoscopy 1982;20:348-351.
41. Rickaert F, Cremer M, Devière J, Tavares L, Lambilliotte JP, Schroder S, et al. Intraductal mucin-hypersecreting neoplasms of the pancreas: a clinicopathologic study of eight patients. Gastroenterology 1991;101:512-519.
42. Jang JY, Kim SW, Ahn YJ, Yoon YS, Choi MG, Lee KU, et al. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery? Ann Surg Oncol 2005;12(2):124-132 (Feb).
43. Sarr MG, Kendrick ML, Nagorney DM, Thompson GB, Farley DR, Farnell MB. Cystic neoplasms of the pancreas: benign to malignant epithelial neoplasms. Surg Clin North Am 2001;81(3):497-509.
44. Cuillerier E, Cellier C, Palazzo L, Deviere J, Wind P, Rickaert F, Cugnenc PH, Cremer M, Barbier JP. Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas. Am J Gastroenterol 2000;95(2):441-445.
45. Azar C, Van de Stadt J, Rickaert F, Deviere M, Baize M, Kloppel G, Gelin M, Cremer M. Intraductal papillary mucinous tumours of the pancreas. Clinical and therapeutic issues in 32 patients. Gut 1996;39(3):457-464.
46. Raimondo M, Tachibana I, Urrutia R, Burgart LJ, DiMagno EP. Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 2002;97(10):2553-2558 (Oct.).
47. Obara T, Maguchi H, Saitoh Y, Itoh A, Arisato S, Ashida T, Nishino N, Ura H, Namiki M. Mucin-producing tumor of the pancreas: natural history and serial pancreatogram changes. Am J Gastroenterol 1993;88:564-569.
48. Doi K, Prentki M, Yip C, Muller WA, Jeanreneaud B, Vrainic M. Identical biological effects of pancreatic glucagons and a purified moiety of canine gastric immunoreactive glucagons. J Clin Invest 1979;63:525-531.
49. Muller WA, Brennan MF, Tan MH, Aoki TT. Studies of glucagon secretion in pancreatectomised patients. Diabetes 1974;23:512-516.
50. Vigili de Kreutzenberg S, Maifreni L, Lisato G, Riccio A, Trevisan R, Tiengo A, DelPrato S. Glucose turnover and recycling in diabetes secondary to total pancreatectomy: effect of glucagons infusion. J Clin Endocrinol Metab 1990;70:1023-1029.
51. Muller WA, Brennan MF, Tan MH, Aoki TT. Studies of glucagon secretion in pancreatectomized patients. Diabetes 1974;23(6):512-516 (Jun).
52. Slezak LA, Andersen DK. Pancreatic resection: effects on glucose metabolism. World J Surg 2001;25:452-460.
53. Boyle PJ. Alteration in brain glucose metabolism induced by hypoglycaemia in man. Diabetologia 1997;40(Suppl 2):S69-S74.
54. Horie H, Matsuyama Namba M, et al. Responses of catecholamines and other counterregulatory hormones to insulin-induced hypoglycemia in totally pancreatectomized patients. J Clin Endocrinol Metab 1984;59:1193-1196.
55. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV. Effective of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 1988;37:901-907.
56. Butler PC, Rizza RA. Regulation of carbohydrate metabolism and response to hypoglycemia. Endocrinol Metab Clin N Am 1989;18(1):1-25 (Mar).
57. Tattersall RB. Brittle diabetes revisited: the Third Arnold Bloom Memorial Lecture. Diabet Med 1997;14(2):99-110 (Feb.).
58. Radermecker RP, Scheen AJ. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness. Diabetes/metab Res Rev 2004;20(3):178-188 (May-Jun).
59. Heptulla RA, Rodriguez LM, Bomgaars L, Haymond MW. The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes. Diabetes 2005;54(4):1100-1107.
60. Bajorunas DR, Fortner JG, Jaspan J, Sherwin RS. Total pancreatectomy increases the metabolic response to glucagon in humans. J Clin Endocrinol Metab 1986;63:439-446.
61. Tankjoh K, Tomita R, Mera K, Hayashi N. Metabolic modulation by concomitant administration of insulin and glucagon in pancreatectomy patients. Hepatogastroentereology 2002;49(44):538-543.
62. Petrides A, DeFronzo RA. Glucose metabolism in cirrhosis: a review with some perspective for the future. Diabetes/metab Rev 1989;5:691-709.
63. Kahl S, Malfertheiner P. Exocrine and endocrine pancreatic insufficiency after pancreatic surgery. Best Pracitce and Research in Clinical Gastroenterology 2004;18:947-955.
64. Dressler CM, Fortner JG, McDermott K, Bajorunas DR. Metabolic consequences of (regional) total pancreatectomy. Ann Surg 1991;214:131-140.
65. Buchler M, Freiss H, Muller M, Wheatley A, Berger H. Randomized trial of duodenum-preserving pancreatic head resection versus pylorus-preserving Whipple in chronic pancreatitis. Am J Surg 1994;65:458-467.
66. Easter DW, Cuschieri A. Total pancreatectomy with preservation of the duodenum and pylorus for chronic pancreatitis. Ann Surg 1991;214:575-580.
67. Alexakis N, Ghaneh P, Connor S, Raraty M, Sutton R, Neoptolemos JP. Duodenum- and spleen preserving total pancreatectomy for end-stage chronic pancreatitis. Br J Surg 2003;90:1401-1408.
68. DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 2004;88(4):787-835 (Jul).
69. Landoni L, Salvia R, Festa L, Muselli P, Giardino A, Butturini G, Falconi M, Bassi C, Pederzoli. Quality of life after total pancreatectomy. Ten-year experience. J Pancreas (Online) 2004;5(5 Suppl):441.
70. Billings BJ, Christein JD, Harmsen WS, Harrington JR, Chari ST, Que FG, Farnell MB, Nagorney DM, Sarr MG. Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up? J Gastrointest Surg 2005;9(8):1059-1067 (Nov-Dec).